Bergen Pursues Legislative, Managerial Remedies for PharMerica
Executive Summary
Reimbursement pressure on Bergen Brunswig's PharMerica long-term care pharmacy business is prompting the parent company to lobby for changes to Medicare's Prospective Payment System.